Ascendis Pharma A/S Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2024: USD 0.00

Ascendis Pharma A/S Common Stock Repurchased is USD 0.00 for the Trailing 12 Months (TTM) ending December 31, 2024, a -100.00% change year over year. Common stock repurchased is cash used to buy back the company’s own shares from the market.
  • Ascendis Pharma A/S Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -2.00 M, a -98.28% change year over year.
  • Ascendis Pharma A/S Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -116.53 M, a 373.80% change year over year.
  • Ascendis Pharma A/S Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -24.59 M.
  • Ascendis Pharma A/S Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 0.00.
Key Data
Date Common Stock Repurchased Free Cash Flow Operating Cash Flow Capital Expenditure